Zensar Technologies Limited provides an update regarding the merger of its US-based subsidiaries. This disclosure is made in continuation of previous communications dated July 29, 2026, and July 31, 2026.
The company confirms that all requisite filings in connection with the merger of M3BI LLC with Zensar Technologies Inc. were completed with the relevant local authorities/state agencies on August 13, 2026. The merger of M3BI LLC with Zensar Technologies Inc. will become effective from September 1, 2026. The company received intimation of this completion at 1:43 a.m. (IST) on August 14, 2026.
With this filing completion, all requisite filings with relevant local authorities/state agencies for the mergers of both Bridgeview Life Sciences LLC and M3BI LLC with Zensar Technologies Inc. have now been completed. Certain post-merger and consequential filings remain under process and are expected to be completed in due course.
The disclosure is signed by Anand Champalal Daga on behalf of Zensar Technologies Limited on August 14, 2026, at 12:27:38 IST.